Potential of Citicoline in Inhibiting Cognitive Function Decline in Mild Cognitive Impairment
Evidence-Based Case Report
DOI:
https://doi.org/10.55175/cdk.v51i8.1210Keywords:
Alzheimer, citicoline, cognitive, mild cognitive impairment, neurologicalAbstract
Background: Citicoline has been associated with the improvement of various neurological conditions. This article aims to explore the potential of citicoline in preventing cognitive decline in mild cognitive impairment (MCI). Methods: A comprehensive literature search was conducted through 10 databases. Studies selected should include adult with cognitive impairment using citicoline. Articles were selected according to specified inclusion and exclusion criteria. A critical review and Level of Evidence assessment is done. Results: From a total of 265 studies obtained, 15 were selected and analyzed. The results show that citicoline has the potential to prevent cognitive decline, in patients with MCI, Alzheimer’s disease, Parkinson’s disease, ischemic stroke, and also in healthy individuals. Although results were varied, citicoline has consistently shown significant improvements in Mini-Mental State Examination (MMSE) scores and other cognitive tests. Conclusion: Citicoline has a potential in preventing cognitive decline in MCI. More research is needed to understand its long-term effects and mechanism of action.
Downloads
References
The influence of the ApoE genotype. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova. 2021;121(10 Vyp 2):30-6. DOI: 10.17116/jnevro202112110230.
Castagna A, Fabbo A, Manzo C, Lacava R, Ruberto C, Ruotolo G. A retrospective study on the benefits of combined citicoline, memantine, and acetylcholinesterase inhibitor treatments in older patients affected with Alzheimer's disease. J Alzheimers Dis. 2021;79(4):1509-15. DOI: 10.3233/JAD-201211.
Bermejo PE, Dorado R, Zea-Sevilla MA. Role of citicoline in patients with mild cognitive impairment. Neurosci Insights 2023;18:26331055231152496. DOI: 10.1177/26331055231152496.
Castagna A, Manzo C, Fabbo A, Lacava R, Ruberto C, Ruotolo G. The CITIMERIVA study: CITIcoline plus MEmantina plus RIVAstigmine in older patients affected with Alzheimer's disease. Clin Drug Investig. 2021;41(2):177-82. DOI: 10.1007/s40261-020-00996-2.
Gavrilova SI, Fedorova YB, Gantman MV, Kalyn YB, Kolykhalov IV. Ceraxon (citicoline) in the treatment of the mild cognitive impairment syndrome. Zhurnal Nevrologii i Psihiatrii imeni SS Korsakova. 2011;111(12):16-20.
Mushba AV, Ivanova DS, Vinogradov OI. Assessing the impact of citicoline on the efficiency of rehabilitation measures in patie nts with ischemic stroke. Zhurnal Nevrologii i Psihiatrii imeni SS Korsakova 2016;2016(2):71-5. DOI: 10.17116/jnevro20161162171-75.
Nemkova SA, Semenov DV, Petrova EA, Zavadenko NN, Vozvyshaeva MY. The effect of the use of the drug recognan (citicoline) on the state of higher mental functions in patients with mild cognitive impairment. Zhurnal nevrologii i psikhiatrii imeni SS Korsakova 2021;121(9):51-7. DOI: 10.17116/jnevro202112109151.
Mashin VV, Belova LA, Bakhtogarimov IR, Bergelson TM, Sharafutdinova RR. Multicenter observational program for evaluation of the effectiveness of the recognan (citicoline) in the correction of cognitive impairment in patients with chronic cerebrovascular pathology. Zhurnal Nevrologii i Psihiatrii imeni SS Korsakova. 2017;117(8):39-43. DOI: 10.17116/jnevro20171178139-43.
Bonvicini M, Travaglini S, Lelli D, Antonelli Incalzi R, Pedone C. Is citicoline effective in preventing and slowing down dementia? A systematic review and a meta-analysis. Nutrients 2023 Jan; 15(2): 386. DOI: 10.3390/nu15020386.
Eriksen MB, Frandsen TF. The impact of patient, intervention, comparison, outcome (PICO) as a search strategy tool on literature search quality: A systematic review. J Med Libr Assoc. 2018;106(4):420-31.
Center for Evidence-Based Medicine. Critical appraisal checklist for therapy study [Internet]. [cited 2023 June 30]. Available from: https://www.cebm.ox.ac.uk/resources/ebm-tools/critical-appraisal-tools.
Howick J, Chalmers I, Lind J, Glasziou P, Greenhalgh T, Heneghan C, et al. Oxford Centre for evidence-based medicine 2011 levels of evidence [Internet]. [cited 2023 June 30]. Available from: http://www.cebm.net/index.aspx?o=5653.
Cotroneo AM, Castagna A, Putignano S, Lacava R, Fantò F, Monteleone F, et al. Effectiveness and safety of citicoline in mild vascular cognitive impairment: The IDEALE study. Clin Interv Aging. 2013;8:131-7. DOI: 10.2147/CIA.S38420.
Nemkova SA, Semenov DV, Zavadenko NN, Vozvyshaeva MY. The influence of the drug recognan (citicoline) on neurodynamic characteristics of mental activity in patients with mild cognitive impairment. Zhurnal Nevrologii i Psihiatrii imeni SS Korsakova. 2021;121(1):43-6. DOI: 10.17116/jnevro202112101143.
Seleznеva ND, Gavrilova SI, Ponomareva EV. Efficacy and safety of citicoline to prevent cognitive deficiency progression in first-degree relatives of patients with Alzheimer’s disease: Prospective study. Psychiatry (Moscow) [Internet]. 2020;18(4):33-40. Available from: https://doi.org/10.30629/2618-6667-2020-18-4-33-40.
Seleznеva ND, Roshchina IF, Ponomareva EV, Gavrilova SI. Citicoline in the treatment of mild cognitive impairment in blood relatives of patients with Alzheimer’s disease: Immediate and long-term Effects of Course Therapy. Psychiatry (Moscow). 2021;19(4):42-51. DOI: 10.17116/jnevro202112110230.
Castagna A, Cotroneo AM, Ruotolo G, Gareri P. The CITIRIVAD study: CITIcoline plus RIVAstigmine in elderly patients affected with dementia study. Clin Drug Investig. 2016;36(12):1059-65. DOI: 10.1007/s40261-016-0454-3.
Gareri P, Castagna A, Cotroneo AM, Putignano D, Conforti R, Santamaria F, et al. The citicholinage study: Citicoline plus cholinesterase inhibitors in aged patients affected with Alzheimer's disease study. J Alzheimers Dis. 2017;56(2):557-65. DOI: 10.3233/JAD-160808.
Li Z, Wang P, Yu Z, Sun H, Zhang J, Cong Y, et al. Effect of citicoline adjuvant therapy on mild cognitive impairment in Parkinson’s disease.2016;9:4593-8.
Nakazaki E, Mah E, Sanoshy K, Citrolo D, Watanabe F. Citicoline and memory function in healthy older adults: A randomized, double-blind, placebo-controlled clinical trial. J Nutr. 2021;151(8):2153-60. DOI: 10.1093/jn/nxab119.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Elvan Wiyarta, Febrilian Kristiawan, Gideon Hot Partogi Sinaga
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
